Hudson Bay Capital Management’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,340
| Closed | -$36.6K | – | 953 |
|
|
2025
Q1 | $36.6K | Buy |
+10,340
| New | +$36.6K | ﹤0.01% | 803 |
|
|
2024
Q3 | – | Sell |
-250,000
| Closed | -$475K | – | 642 |
|
|
2024
Q2 | $475K | Sell |
250,000
-248,000
| -50% | -$471K | ﹤0.01% | 524 |
|
|
2024
Q1 | $1.41M | Buy |
498,000
+37,400
| +8% | +$106K | 0.01% | 427 |
|
|
2023
Q4 | $6.78M | Sell |
460,600
-221,623
| -32% | -$3.26M | 0.04% | 219 |
|
|
2023
Q3 | $12.5M | Buy |
682,223
+391,323
| +135% | +$7.17M | 0.1% | 110 |
|
|
2023
Q2 | $6.27M | Buy |
+290,900
| New | +$6.27M | 0.05% | 229 |
|